A detailed history of Comerica Bank transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 189 shares of JANX stock, worth $5,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189
Previous 61 209.84%
Holding current value
$5,955
Previous $2,000 400.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$40.18 - $66.83 $5,143 - $8,554
128 Added 209.84%
189 $10,000
Q2 2024

Aug 15, 2024

BUY
$35.12 - $64.78 $2,142 - $3,951
61 New
61 $2,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.31B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.